Title : P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice.

Pub. Date : 2019 Feb 10

PMID : 30553002






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice. quizartinib ATP binding cassette subfamily G member 2 (Junior blood group) Mus musculus
2 P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice. quizartinib ATP binding cassette subfamily G member 2 (Junior blood group) Mus musculus
3 Quizartinib was transported by human ABCB1 in vitro, and by mouse (m)Abcb1 and mAbcg2 in vivo. quizartinib ATP binding cassette subfamily G member 2 (Junior blood group) Mus musculus
4 Upon oral administration, the brain accumulation of quizartinib was 6-fold decreased by mAbcb1 and 2-fold by mAbcg2 (together: 12-fold). quizartinib ATP binding cassette subfamily G member 2 (Junior blood group) Mus musculus